Assessment of response to induction therapy and its influence on 5-year failure-free survival (FFS) in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study ORSHV experience Meeting Abstract


Authors: Breitfeld, P. P.; Anderson, J.; Kao, S.; Rodeberg, D.; Qualman, S.; Wolden, S.; Meyer, W.
Abstract Title: Assessment of response to induction therapy and its influence on 5-year failure-free survival (FFS) in Group III rhabdomyosarcoma (RMS): Intergroup Rhabdomyosarcoma Study ORSHV experience
Meeting Title: 40th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 22
Issue: 14 Suppl.
Meeting Dates: 2004 Jun 5-8
Meeting Location: New Orleans, LA
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2004-07-15
Start Page: 802S
Language: English
ACCESSION: WOS:000223512403183
PROVIDER: wos
Notes: Meeting Abstract: 8513 -- 40th Annual Meeting of the American-Society-of-Clinical-Oncology -- JUN 05-08, 2004 -- New Orleans, LA -- S -- Source: Wos
MSK Authors
  1. Suzanne L Wolden
    419 Wolden
Related MSK Work